MedTrace Logo

Effect of Pretreatment of Lignocaine Versus Midazolam in Prevention of Etomidate Induced Myoclonus.

NCT04921046 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2021-06-10

No results posted yet for this study

Summary

This study is a randomized control trial and it was conducted to compare the effectiveness of pretreatment with lignocaine versus midazolam on the frequency of myoclonus associated with etomidate induction.

This was conducted in Holy Family Hospital Rawalpindi in a period of 6 months.

Conditions

  • Myoclonic Jerk

Interventions

DRUG

lignocaine

After giving lignocaine to a group of people, myoclonus was observed after the dose of etomidate given two minutes after lignocaine.

DRUG

Midazolam 1 milligram Prefilled Syringe

after giving midazolam to the second group of people two minutes before etomidate dose, myoclonus was observed for one minute.

Sponsors & Collaborators

  • Rawalpindi Medical College

    lead OTHER

Principal Investigators

  • Fizza Batool, FCPS · Rawalpindi Medical College

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-06-30
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04921046 on ClinicalTrials.gov